119 results on '"Herrmann Nathan"'
Search Results
2. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
3. Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive Disorder
4. Diagnostic Precision in the Detection of Mild Cognitive Impairment: A Comparison of Two Approaches
5. Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older Adults
6. Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors
7. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
8. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
9. The Interplay Between Post-traumatic Stress Disorder and Dementia: A Systematic Review
10. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
11. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
12. Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression
13. Examining the sex-specific association between APOE ε4 status and increased neuropsychiatric symptom burden in populations at risk for Alzheimer's disease
14. Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications
15. Correlation between changes in apathy and global cognition in apathetic associated with Alzheimer's disease: analysis of the Apathy Dementia Methylphenidate 2 (ADMET 2) clinical trial
16. The Relationship Between Grey Matter Atrophy and Apathy Severity in Alzheimer's, Parkinson's, and Mixed Dementia: A COMPASS-ND study
17. A meta-analysis of neurofilament light chain as a biomarker for mild cognitive impairment
18. Changes in brain glutathione in patients with mild vascular cognitive impairment
19. Brain-cognition associations in late-life depression or mild cognitive impairment: A multivariate analysis of white and gray matter integrity
20. Neuropsychiatric symptoms and their relationship with white matter hyperintensities in mild vascular cognitive impairment, mild cognitive impairment, Alzheimer's disease and mixed dementia – a COMPASS-ND study
21. Cost Consequence Analysis of ADMET 2
22. Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004–2013
23. White Matter Microstructural Integrity Is Associated with Executive Function and Processing Speed in Older Adults with Coronary Artery Disease
24. Developing Physician Consensus on the Reporting of Patients with Mild Cognitive Impairment and Mild Dementia to Transportation Authorities in a Region with Mandatory Reporting Legislation
25. Prevalence and Correlates of Renal Disease in Older Lithium Users: A Population-Based Study
26. Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET)
27. Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia
28. Antipsychotics and Mortality in Parkinsonism
29. Antipsychotic Drugs and the Risk of Hyperglycemia in Older Adults Without Diabetes: A Population-Based Observational Study
30. At-Fault Motor Vehicle Crash Risk in Elderly Patients Treated With Antidepressants
31. PAS-MCI: Design and Rationale for a Randomized Controlled Trial to Enhance Prefrontal Cortical Plasticity and Working Memory in Individuals with Amnestic Mild Cognitive Impairment
32. Senescence Markers and Apathy Symptoms in Patients with Mild Cognitive Impairment and/or Remitted Major Depression: An Analysis of the PACt-MD Study
33. Apathy Associated with Alzheimer Disease: Use of Dextroamphetamine Challenge
34. Comorbid Depression and Anxiety in Later Life: Patterns of Association, Subjective Well-being, and Impairment
35. A Positron Emission Tomography Study of 5-Hydroxytryptamine-1A Receptors in Alzheimer Disease
36. Epidemiology of Social Phobia in Later Life
37. A descriptive study of older medical cannabis users in medical cannabis clinics
38. The Modulatory Effect of Sex on the Association between APOE and Neuropsychiatric Symptom Burden in Older Adults at Risk for Alzheimer's Disease.
39. Prevalence and Correlates of Agoraphobia in Older Adults
40. Outcome After Traumatic Brain Injury Sustained in Older Adulthood: A One-Year Longitudinal Study
41. EVALUATING THE COGNITIVE EFFECTS OF EXERCISE PRIMING AND TRANSCRANIAL DIRECT CURRENT STIMULATION IN MILD COGNITIVE IMPAIRMENT AND MILD ALZHEIMER'S DISEASE: THE EXPRESS STUDY
42. Mental Health-Related Drug Utilization Among Older Adults: Prevalence, Trends, and Costs
43. Galantamine Treatment of Problematic Behavior in Alzheimer Disease: Post-Hoc Analysis of Pooled Data From Three Large Trials
44. CARDIOVASCULAR BURDEN AND COGNITION IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT AND MAJOR DEPRESSIVE DISORDER
45. EXAMINING THE IMPACT OF CARDIOVASCULAR RISK FACTORS ON NEUROPSYCHIATRIC SYMPTOMS IN THE PACT-MD STUDY
46. DIAGNOSING COGNITIVE DECLINE: COMPARING NIA-AA TO DSM-5 APPROACHES
47. Cholinesterase Inhibitor Discontinuation: The Buck Stops Here
48. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
49. Patient-Related Factors Predicting Physician Reporting of Drivers With Mild Dementia and Mild Cognitive Impairment to Transportation Authorities: A Consensus Study
50. Changing Patterns of Sedative Use Over Time in Older Adults in Ontario
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.